These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17220275)

  • 41. A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma.
    Wallace EM; Rizzi JP; Han G; Wehn PM; Cao Z; Du X; Cheng T; Czerwinski RM; Dixon DD; Goggin BS; Grina JA; Halfmann MM; Maddie MA; Olive SR; Schlachter ST; Tan H; Wang B; Wang K; Xie S; Xu R; Yang H; Josey JA
    Cancer Res; 2016 Sep; 76(18):5491-500. PubMed ID: 27635045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miRNA-182-5p, via HIF2α, contributes to arsenic carcinogenesis: evidence from human renal epithelial cells.
    Fang X; Sun R; Hu Y; Wang H; Guo Y; Yang B; Pi J; Xu Y
    Metallomics; 2018 Nov; 10(11):1607-1617. PubMed ID: 30334557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2α-Targeting Therapy for Renal Cell Carcinoma.
    Yoshino H; Nohata N; Miyamoto K; Yonemori M; Sakaguchi T; Sugita S; Itesako T; Kofuji S; Nakagawa M; Dahiya R; Enokida H
    Cancer Res; 2017 Nov; 77(22):6321-6329. PubMed ID: 28951458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cathepsins L and B target HIF1α for oxygen-independent proteolytic cleavage.
    Stuart S; Tarade D; Ohh M
    Sci Rep; 2024 Jun; 14(1):14799. PubMed ID: 38926538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypoxia-inducible factor-2α activation promotes colorectal cancer progression by dysregulating iron homeostasis.
    Xue X; Taylor M; Anderson E; Hao C; Qu A; Greenson JK; Zimmermann EM; Gonzalez FJ; Shah YM
    Cancer Res; 2012 May; 72(9):2285-93. PubMed ID: 22419665
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIF2α/EFEMP1 cascade mediates hypoxic effects on breast cancer stem cell hierarchy.
    Kwak JH; Lee NH; Lee HY; Hong IS; Nam JS
    Oncotarget; 2016 Jul; 7(28):43518-43533. PubMed ID: 27270657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of HIF2α in kidney proximal tubule cells causes abnormal glycogen deposition but not tumorigenesis.
    Fu L; Wang G; Shevchuk MM; Nanus DM; Gudas LJ
    Cancer Res; 2013 May; 73(9):2916-25. PubMed ID: 23447580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role Of Hif2α Oxygen Sensing Pathway In Bronchial Epithelial Club Cell Proliferation.
    Torres-Capelli M; Marsboom G; Li QO; Tello D; Rodriguez FM; Alonso T; Sanchez-Madrid F; García-Rio F; Ancochea J; Aragonés J
    Sci Rep; 2016 May; 6():25357. PubMed ID: 27150457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIF2α is involved in the expansion of CXCR4-positive cancer stem-like cells in renal cell carcinoma.
    Micucci C; Matacchione G; Valli D; Orciari S; Catalano A
    Br J Cancer; 2015 Oct; 113(8):1178-85. PubMed ID: 26439684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural and functional analysis of amphioxus HIFα reveals ancient features of the HIFα family.
    Gao S; Lu L; Bai Y; Zhang P; Song W; Duan C
    FASEB J; 2014 Apr; 28(4):1880-90. PubMed ID: 24174425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α.
    Schöning JP; Monteiro M; Gu W
    Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):153-161. PubMed ID: 27809360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modified Hypoxia-Inducible Factor Expression in CD8
    Veliça P; Cunha PP; Vojnovic N; Foskolou IP; Bargiela D; Gojkovic M; Rundqvist H; Johnson RS
    Cancer Immunol Res; 2021 Apr; 9(4):401-414. PubMed ID: 33602720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma.
    Koh MY; Nguyen V; Lemos R; Darnay BG; Kiriakova G; Abdelmelek M; Ho TH; Karam J; Monzon FA; Jonasch E; Powis G
    Cancer Res; 2015 Jan; 75(2):316-29. PubMed ID: 25421578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Notch signaling promotes a HIF2α-driven hypoxic response in multiple tumor cell types.
    Mutvei AP; Landor SK; Fox R; Braune EB; Tsoi YL; Phoon YP; Sahlgren C; Hartman J; Bergh J; Jin S; Lendahl U
    Oncogene; 2018 Nov; 37(46):6083-6095. PubMed ID: 29993038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypoxia-inducible factors and the response to hypoxic stress.
    Majmundar AJ; Wong WJ; Simon MC
    Mol Cell; 2010 Oct; 40(2):294-309. PubMed ID: 20965423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vulnerability of HIF1α and HIF2α to damage by proteotoxic stressors.
    Meyers LM; Krawic C; Luczak MW; Zhitkovich A
    Toxicol Appl Pharmacol; 2022 Jun; 445():116041. PubMed ID: 35504338
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The EGLN-HIF O
    Ivan M; Kaelin WG
    Mol Cell; 2017 Jun; 66(6):772-779. PubMed ID: 28622522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs.
    Arnaiz E; Miar A; Bridges E; Prasad N; Hatch SB; Ebner D; Lawrie CH; Harris AL
    BMC Cancer; 2021 Aug; 21(1):896. PubMed ID: 34353313
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HIF3α: the little we know.
    Ravenna L; Salvatori L; Russo MA
    FEBS J; 2016 Mar; 283(6):993-1003. PubMed ID: 26507580
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypoxia-inducible factor-2alpha: effect on radiation sensitivity and differential regulation by an mTOR inhibitor.
    Bhatt RS; Landis DM; Zimmer M; Torregrossa J; Chen S; Sukhatme VP; Iliopoulos O; Balk S; Bubley GJ
    BJU Int; 2008 Aug; 102(3):358-63. PubMed ID: 18394010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.